688506 Stock Overview
Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Sichuan Biokin Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥125.05 |
52 Week High | CN¥157.33 |
52 Week Low | CN¥61.11 |
Beta | 0 |
1 Month Change | 5.01% |
3 Month Change | -11.63% |
1 Year Change | 83.41% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 290.17% |
Recent News & Updates
Recent updates
Shareholder Returns
688506 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -10.9% | -3.4% | -2.2% |
1Y | 83.4% | -11.4% | -14.8% |
Return vs Industry: 688506 exceeded the CN Pharmaceuticals industry which returned -11.4% over the past year.
Return vs Market: 688506 exceeded the CN Market which returned -14.8% over the past year.
Price Volatility
688506 volatility | |
---|---|
688506 Average Weekly Movement | 8.2% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 8.1% |
10% most volatile stocks in CN Market | 11.4% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 688506 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688506's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 2,159 | Yi Zhu | https://www.baili-pharm.com |
Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd. Fundamentals Summary
688506 fundamental statistics | |
---|---|
Market cap | CN¥50.93b |
Earnings (TTM) | -CN¥763.90m |
Revenue (TTM) | CN¥561.87m |
89.2x
P/S Ratio-65.6x
P/E RatioIs 688506 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688506 income statement (TTM) | |
---|---|
Revenue | CN¥561.87m |
Cost of Revenue | CN¥0 |
Gross Profit | CN¥561.87m |
Other Expenses | CN¥1.33b |
Earnings | -CN¥763.90m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 27, 2024
Earnings per share (EPS) | -1.90 |
Gross Margin | 100.00% |
Net Profit Margin | -135.96% |
Debt/Equity Ratio | 79.9% |
How did 688506 perform over the long term?
See historical performance and comparison